Sirion Holdings, Inc. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- PROPOSAL FOR: Stability Program for Difluprednate Ophtahlmic Solution for Sirion Therapeutics (Filed With SEC on September 18, 2006)
- SUBMITTED TO: (Filed With SEC on September 18, 2006)
- QUOTATION (Filed With SEC on September 18, 2006)
- QUOTATION (Filed With SEC on September 18, 2006)
- QUOTATION (Filed With SEC on September 18, 2006)
- Appendix I-1 (Filed With SEC on September 18, 2006)
- Confidential EXECUTION VERSION SIRION THERAPEUTICS, INC. (Filed With SEC on September 18, 2006)
- RxDR Rogellen Partners, Inc. By: /s/ Barry Butler By: /s/ Roger Vogel Barry Butler Partner/CEO Roger Vogel, MD, President By: /s/ Roger Vogel Roger Vogel, MD Partner/CMO (Filed With SEC on September 18, 2006)
- RxDR BPI By: /s/ Barry Butler By: /s/ Barry Butler Barry Butler Partner/CEO Barry Butler, President By: /s/ Roger Vogel Roger Vogel, MD Partner/CMO (Filed With SEC on September 18, 2006)
- Date: April 25, 2006To: William StringerFrom: Barry ButlerSubject: Offer letter (Filed With SEC on September 18, 2006)
- Date: April 25, 2006To: Dawn Bennet JohnsonFrom: Barry ButlerSubject: Offer letter (Filed With SEC on September 18, 2006)
- TENBY PHARMA INC. (Filed With SEC on September 18, 2006)
